The University of Liverpool has adopted Achiever LIMS to support the "Children Growing up in Liverpool" (C-GULL) longitudinal birth cohort study. Achiever LIMS facilitates a fully paperless workflow, integrating seamlessly with external systems to ensure efficient sample management and accurate patient consent tracking. This collaboration exemplifies the power of technology in advancing public health research. Read the case study in full: https://loom.ly/oaAjoN8 #PublicHealth #LaboratoryManagement #AchieverLIMS #HealthEquity
Interactive Software Ltd’s Post
More Relevant Posts
-
The third number of Clinical Innovations in Health Research-HJM can be consulted by clicking the following link:https://lnkd.in/g-vYuGkc #ClinicalTrials #research #Academy #PhD #MedicalCollege #HealthAndWellness #ClinicalMedicine #NurseLife #PhDlife #PhDposition #phdvoice
To view or add a comment, sign in
-
Interested in innovative clinical trial strategies that go beyond the traditional approach? 🌟 Join us on Wednesday, October 2nd, 2024 @1:00 PM ET to discover how industry leaders are leveraging data on social determinants of health (SDOH) like housing, health literacy, transportation, and social support to revolutionize recruitment, retention, and evidence generation! #ClinicalTrials #SDOH #HealthcareInnovation
To view or add a comment, sign in
-
Increasing diversity in clinical trials and all research is vital in understanding how health interventions can affect patients differently. Altura CEO Pete Fronte, MBA chaired a forum on this topic at the DIA 2024 Global Annual Meeting in June. Dr. Karen Correa, PhD,BCMAS, Takeda; Dr. Jim Schultz, Neighborhood Healthcare; and clinical trial patient Mario DuCre discussed how community health centers (CHCs) and life science companies can play a key role in boosting clinical study involvement among underrepresented populations. View the presentation: #diversity #healthequity #clinicalresearch #chcs #lifesciences
To view or add a comment, sign in
-
iConquerMS relies on the MS community to shape research. From health data to research topics, your input drives progress in MS care. Discover more: https://lnkd.in/gqtqysgE #iConquerMS10Years #MS #MSResearch
To view or add a comment, sign in
-
✨Applications Now Open for the CORE Network of Excellence! The CORE (Collaboration, Outreach, Research & Education) Network of Excellence is a global network of healthcare professionals who accelerate access to care through collaboration, peer-to-peer education, and research. The CORE Program was created to address the deep need for improved access to care globally for those impacted by the Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorders (HSD), and aims to: ● Deepen clinical understanding of EDS & HSD diagnosis and management ● Identify opportunities for systemic improvements ● Advocate for change with data-driven insights Applications are now open. To become a CORE Network member, learn more here: https://lnkd.in/e9rC4Zug #EhlersDanlos #EhlersDanlosSyndrome #Hypermobility #HypermobilitySyndrome #HypermobilitySpectrumDisorder #Healthcare #HealthProfessionals #Medicine
To view or add a comment, sign in
-
-
🧪🔬🧫🥼🧬👩🔬 Clinical trials can drive medical innovation and improve global health outcomes. Check out World Health Organization's latest Guidance for best practices for clinical trials ➡️https://lnkd.in/e4MiYXSn
Now that the new WHO Guidance for best practices for clinical trials is available, lets unlock the potential of clinical research to drive solutions for public health challenges. We will post weekly threads on practical changes the guidance is calling for to create an enabling environment for generation of high quality evidence, and for careers for clinical researchers. Together, we can ensure better health outcomes worldwide. #ClinicalTrials, #GlobalHealth, #ResearchImpact, #GatesFoundation, #EDCTP, #NIH, #NIHR, #WellcomeTrust, #GlobalHealthNetwork, #CIOMS, #GlobalClinicalTrials, #ICYMI,
To view or add a comment, sign in
-
-
i-Cubed has three main goals for its partnership with the Biomedical Advanced Research and Development Authority (BARDA) D-COHRe program: 1. Evaluate the value of Decentralized Clinical Trials (DCT) for public health emergency response 2. Collaborate with national DCT stakeholders to identify and prioritize areas of greatest need 3. Establish a sustainable framework to evaluate and deploy innovative DCT Together, we’re building a future where clinical research is accessible, inclusive, and ready to handle public health emergencies: duke.is/BARDA #PublicHealth #DecentralizedTrials #ClinicalInnovation #iCubed
To view or add a comment, sign in
-
New study in #HSR Wiley from Amanda C. Blok PhD, MSN, RN, PHCNS-BC et al examines the relationship between site-level adaptation and early adoption of Caregivers Finding Important Resources, Support, and Training (FIRST) training during national implementation across diverse Veteran Health Administration (VA) medical centers. WHAT IS KNOWN: Interventions developed and tested in research settings are rarely adopted in real-world settings. WHAT THIS STUDY ADDS: This study uses novel survey methodologies for reporting intervention adaptations in real-world practice settings in a proactive, theoretically sound, and streamlined manner. CONCLUSION: Site-level adaptations were diverse and occurred more frequently in sites with early adoption of Caregivers FIRST. Read the full article: https://lnkd.in/dYwvQM5M
To view or add a comment, sign in
-
-
📣New Evidence on the Lived Experience of People with Multiple Long-Term Conditions (MLTCs) A significant publication from the MELD-B project offers new insights into the impact of living with multimorbidity. The study synthesizes qualitative evidence on the work associated with managing MLTCs—showing that this work is not just about medications and healthcare use. It includes a complex emotional, financial, and administrative burden that requires constant learning and adaptation. Key findings from the study include: -Emotional work: The mental toll of managing multiple conditions -Financial work: Costs of care and time off work -Learning & adapting: Continuous adjustment to new health challenges -Administrative burden: Managing appointments, medications, and healthcare systems The research highlights gaps in existing healthcare systems in addressing the everyday burden of MLTCs and calls for more patient involvement in future research. This study is an important step in understanding multimorbidity beyond clinical outcomes—focusing on how it shapes people's daily lives. 📄 Read the full publication: https://buff.ly/4j7c0N2 👉Read more about the project: https://buff.ly/4j466MA #Multimorbidity #MLTCs #HealthResearch #LivedExperience #HealthInequalities
To view or add a comment, sign in
-
-
Clinical research is the heart of all medical advances.
Now that the new WHO Guidance for best practices for clinical trials is available, lets unlock the potential of clinical research to drive solutions for public health challenges. We will post weekly threads on practical changes the guidance is calling for to create an enabling environment for generation of high quality evidence, and for careers for clinical researchers. Together, we can ensure better health outcomes worldwide. #ClinicalTrials, #GlobalHealth, #ResearchImpact, #GatesFoundation, #EDCTP, #NIH, #NIHR, #WellcomeTrust, #GlobalHealthNetwork, #CIOMS, #GlobalClinicalTrials, #ICYMI,
To view or add a comment, sign in
-